A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
Novartis
Novartis
Novartis
Intensity Therapeutics, Inc.
Agenus Inc.
Columbia University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Herlev and Gentofte Hospital
Asan Medical Center
Novartis
Agenus Inc.
Assaf-Harofeh Medical Center